Company intelligence / Profile preview

ChemCom

Brussels, Brussels-Capital Region, Belgiumchemcom.be ↗

Ownership: Private
Employees: ~13
Development stage: Commercial

Overview

ChemCom has developed a unique platform to deorphanize over 120 human olfactory receptors using a chemical library of more than 7,000 compounds. Their technology enables high-throughput screening to identify ligands that activate specific sensory GPCRs. Applications include flavors & fragrances, consumer products, odor management solutions, with some projects exploring pharmaceutical targets in oncology and immunology through partnerships

Therapeutic areas: ImmunologyOtherDermatologyOncology
Modalities: Small moleculePeptides
Industry: Non-Drug Biotech

Partnerships

GivaudanSymrise

Beyond the preview

Go deeper on ChemCom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemCom.

Explore the full profile